Novartis Home
At Novartis, we are reimagining medicine
At Novartis, we are reimagining medicine
Novartis R&D Day
Novartis shares progress in advancing its industry-leading R&D pipeline. We are uniquely positioned to deliver transformational treatments through our scale, focus on innovative medicines, diverse range of therapeutic areas and exposure to cutting-edge platforms.
Accelerating our digital transformation with Amazon Web Services (AWS)
We are collaborating with AWS to build an enterprise-wide data and analytics platform to help transform business operations, starting with the way medicines are manufactured and delivered.
"I'm really proud of how our teams are already starting to work together. Co-creating solutions with bi-weekly sprints in a true product mindset."
Latest News
Novartis on Twitter
New cell and gene facility inaugurated in Switzerland
Novartis opens facility for innovative cell and gene therapies at our Stein manufacturing site in the canton of Aargau.
Can data from a heart disease trial lead to a potential cancer treatment?
Novartis researchers are learning how a novel approach to immunotherapy could help treat cancer.